EA201001340A1 - Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор - Google Patents

Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор

Info

Publication number
EA201001340A1
EA201001340A1 EA201001340A EA201001340A EA201001340A1 EA 201001340 A1 EA201001340 A1 EA 201001340A1 EA 201001340 A EA201001340 A EA 201001340A EA 201001340 A EA201001340 A EA 201001340A EA 201001340 A1 EA201001340 A1 EA 201001340A1
Authority
EA
Eurasian Patent Office
Prior art keywords
diagnostic kit
determination
analytical method
application
hepatitis
Prior art date
Application number
EA201001340A
Other languages
English (en)
Inventor
Висенте Карреньо-Гарсиа
Фернандо-Хавьер Бартоломе-Небреда
Инмакулада Кастильо-Агилар
Хуан-Антонио Кирога-Эстевес
Original Assignee
Фундасьон Пара Эль Эстудио Де Лас Эпатитис Виралес
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фундасьон Пара Эль Эстудио Де Лас Эпатитис Виралес filed Critical Фундасьон Пара Эль Эстудио Де Лас Эпатитис Виралес
Publication of EA201001340A1 publication Critical patent/EA201001340A1/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Данное изобретение относится к улучшенному аналитическому способу для определения латентного гепатита С, к его применению и к соответствующему диагностическому набору. Аналитический способ основывается на методике иммуноанализа и наиболее приемлемых параметрах осуществления для определения латентного гепатита С. Изобретение также относится к диагностическому набору, дополняющему данный способ. Изобретение является приемлемым для применения в медицине, биомедицинском исследовании и в области аналитических методик.
EA201001340A 2008-02-21 2009-01-16 Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор EA201001340A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200800493A ES2303496B1 (es) 2008-02-21 2008-02-21 Metodo analitico perfeccionado para la deteccion de hepatitis c oculta, aplicaciones del mismo y su correspondiente kit de diagnostico.
PCT/ES2009/000019 WO2009103828A1 (es) 2008-02-21 2009-01-16 Método analítico perfeccionado para la detección de hepatitis c oculta, aplicaciones del mismo y su correspondiente kit de diagnóstico

Publications (1)

Publication Number Publication Date
EA201001340A1 true EA201001340A1 (ru) 2011-04-29

Family

ID=39637059

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001340A EA201001340A1 (ru) 2008-02-21 2009-01-16 Улучшенный аналитический способ для определения латентного гепатита с, его применения и соответствующий диагностический набор

Country Status (7)

Country Link
US (1) US20110183364A1 (ru)
EP (1) EP2258714B1 (ru)
KR (1) KR101561893B1 (ru)
CN (1) CN102046649B (ru)
EA (1) EA201001340A1 (ru)
ES (1) ES2303496B1 (ru)
WO (1) WO2009103828A1 (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014016301A1 (en) * 2012-07-23 2014-01-30 Institut National De La Sante Et De La Recherche Medicale (Inserm) A protein microarray for characterizing the specificity of the monoclonal immunoglobulins of mgus or myeloma patients

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0754704T3 (da) * 1990-12-14 2000-04-03 Innogenetics Nv Syntetiske antigener til påvisning af antistoffer mod hepatitis c-virus
US6667387B1 (en) * 1996-09-30 2003-12-23 N.V. Innogenetics S.A. HCV core peptides
FR2690921B1 (fr) * 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
EP0992580B1 (en) * 1993-11-04 2005-03-09 Innogenetics N.V. Immunodominant human T-cell epitopes of Hepatitis C virus
JP3514729B2 (ja) * 1998-07-30 2004-03-31 株式会社先端生命科学研究所 Ｃ型肝炎ウイルスの測定方法

Also Published As

Publication number Publication date
KR101561893B1 (ko) 2015-10-21
CN102046649B (zh) 2015-04-08
EP2258714A1 (en) 2010-12-08
EP2258714B1 (en) 2015-02-25
KR20100138963A (ko) 2010-12-31
ES2303496A1 (es) 2008-08-01
CN102046649A (zh) 2011-05-04
EP2258714A4 (en) 2011-04-13
US20110183364A1 (en) 2011-07-28
WO2009103828A1 (es) 2009-08-27
ES2303496B1 (es) 2009-07-07

Similar Documents

Publication Publication Date Title
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
BRPI0414030A (pt) método para detectar desordens neoplásicas em uma amostra corporal solubilizada
TW200643400A (en) Optical-based sensing devices
DK1668368T3 (da) Detektion af histon-modifikation i cellefrie nukleosomer
WO2010057184A3 (en) Methods for detection of acute kidney injury in humans
WO2010132453A3 (en) Methods and compositions for analyte detection
EP4335932A3 (en) Methods of monitoring conditions by sequence analysis
NZ601022A (en) Diagnosis and treatment of cancer using anti-ereg antibody
WO2007061793A3 (en) Modified cardiolipin and uses therefor
WO2007098184A3 (en) Methods and compositions for analyte detection
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
DE602006016589D1 (de) Neue markierungsstrategien für den empfindlichen nachweis von analyten
EP2566983A4 (en) SERIAL ANALYSIS OF BIOMARKERS FOR THE DIAGNOSIS OF A DISEASE
BR112012009846B8 (pt) método in vitro e kit para detecção de um anticorpo antifármaco de isotipo ige, e uso de um anticorpo antifármaco de isotipo ige no tratamento de distúrbio mediado por ige
DK2094845T3 (da) Kunstige bindingsproteiner baseret på et modificeret alpha helix-område af ubiquitin
WO2013078424A3 (en) Versatile and sensitive biosensor
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
WO2011015602A3 (en) Lung cancer biomarkers
RU2011141857A (ru) Способ непрерывного измерения концентрации субстрата
IL202598A0 (en) High sensitivity immunoassays and kits for the determination of peptides and proteins of biological interest
CY1112423T1 (el) Αναλυτικη συσκευη μικροεπεξεργαστη μιας χρησης
WO2011109112A3 (en) Method of detecting tau protein and tau fragments in serum
SE0602683L (sv) Diagnostisk metod
MX2013002652A (es) Metodos y equipos para la deteccion de una infeccion en sujetos con bajos niveles de anticuerpos especificos.